Sacubitril/Valsartan-induced Angioedema. [PDF]
Hiraoka Y, Nagayama K.
europepmc +1 more source
Risk of Hyperkalemia in Patients with Heart Failure Treated with Spironolactone in Combination with Sacubitril/Valsartan vs. Renin-Angiotensin System Inhibitors. [PDF]
Crum KL, Vaduganathan M, Desai RJ.
europepmc +1 more source
Long-term environmental risk assessment of glufosinate-tolerant GM zoysiagrass (<i>Zoysia japonica</i> Steud.) on non-target arthropod communities. [PDF]
Jang YJ +8 more
europepmc +1 more source
Effects of Qili Qiangxin granules in combination with Entresto on quantitative parameters of myocardial motion in patients with cardiomyopathy in end-stage renal disease. [PDF]
Li Y, Liu L, Wang F.
europepmc +1 more source
Sacubitril/valsartan as a modulator of pulmonary fibrosis: insights into Lnc-SNHG-16/miR-455 modulation and Notch/Smad-3 pathway inhibition. [PDF]
Abdel-Nasser ZM, Zaafan MA.
europepmc +1 more source
Spatial Distribution of Astins in <i>Aster tataricus</i> and Their Production by <i>Cyanodermella asteris</i>. [PDF]
Barrera-Adame DA +2 more
europepmc +1 more source
Clinical outcomes of heart failure with improved ejection fraction in patients treated with angiotensin receptor-neprilysin inhibitor. [PDF]
Kim DE +13 more
europepmc +1 more source
Effect of sacubitril/valsartan and SGLT2 inhibitors on arrhythmia burden in ICD patients. [PDF]
Öztürk F, Yaman M.
europepmc +1 more source
Sacubitril/valsartan attenuates renal injury caused by cecal ligation and puncture via TLR4/NFκB/NLRP3 inhibition and reduced oxidative stress and apoptosis in rats. [PDF]
Mohyeldin RH +6 more
europepmc +1 more source
Cardiac biomarkers response under angiotensin receptor-neprilysin inhibitor: a sub-analysis of the NATRIUM-HF study. [PDF]
Bruno J +15 more
europepmc +1 more source

